Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.76T
Total marketcap
$47.41B
Total volume
BTC 59.87%     ETH 7.88%
Dominance

BLPH Stock

0.01 {{ price }} 0.000000% {{change_pct}}%
Market Cap
0
LOW - HIGH [24H]
0.0000 - 0.0000
VOLUME [24H]
0
{{ volume }}
P/E Ratio
0
Earnings per share
0

Price Chart

BLPH Financial and Trading Overview

stock price 0.01
Previous Close 0.7
Open 0.72
Bid 0 x 800
Ask 0 x 1800
Day's Range 0.69 - 0.72
52 Week Range 0.67 - 12.58
Volume 598.4K
Avg. Volume 547.22K
Market Cap 7.37M
Beta (5Y Monthly) 0.895847
PE Ratio (TTM) N/A
EPS (TTM) 0
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 10.5

BLPH Valuation Measures

Enterprise Value -7619220
Trailing P/E N/A
Forward P/E -0.48273972
PEG Ratio (5 yr expected) 0
Price/Sales (ttm) 1.3058544
Price/Book (mrq) 0.6943843
Enterprise Value/Revenue -1.351
Enterprise Value/EBITDA 0.501

Trading Information

Stock Price History

Beta (5Y Monthly) 0.895847
52-Week Change -18.023%
S&P500 52-Week Change 20.43%
52 Week High 12.58
52 Week Low 0.67
50-Day Moving Average 7.45
200-Day Moving Average 3.5

BLPH Share Statistics

Avg. Volume (3 month) 547.22K
Avg. Daily Volume (10-Days) 2.43M
Shares Outstanding 10.45M
Float 7.05M
Short Ratio 2.64
% Held by Insiders 4.11%
% Held by Institutions 44.42%
Shares Short 346.98K
Short % of Float 4.19%
Short % of Shares Outstanding 3.31%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:15

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -201.56%
Operating Margin (ttm) -270.70%
Gross Margin 100.00%
EBITDA Margin -269.91%

Management Effectiveness

Return on Assets (ttm) -50.60%
Return on Equity (ttm) -84.92%

Income Statement

Revenue (ttm) 5.64M
Revenue Per Share (ttm) 0.58
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -15223000
Net Income Avi to Common (ttm) -11368000
Diluted EPS (ttm) -1.07
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 15.17M
Total Cash Per Share (mrq) 1.45
Total Debt (mrq) 8K
Total Debt/Equity (mrq) 0.08
Current Ratio (mrq) 2.94
Book Value Per Share (mrq) 1.015

Cash Flow Statement

Operating Cash Flow (ttm) -9768000
Levered Free Cash Flow (ttm) -8167500

Profile of

Country United States
State NJ
City Warren
Address 20 Independence Boulevard
ZIP 07059
Phone (908) 574-4770
Website https://bellerophon.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 18

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse, which is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

Q&A For Stock

What is a current BLPH stock price?

BLPH stock price today per share is 0.01 .

How to purchase stock?

You can buy BLPH shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ?

The stock symbol or ticker of is BLPH.

Which industry does the company belong to?

The industry is Biotechnology.

How many shares does have in circulation?

The max supply of shares is 0.

What is Price to Earnings Ratio (PE Ratio)?

PE Ratio is 0.00000000 now.

What was earnings per share over the trailing 12 months (TTM)?

EPS is 0 over the trailing 12 months.

Which sector does the company belong to?

The sector is Healthcare.

BLPH included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15587.79 USD
-5.82
9.14B USD 15575.68 USD 16128.16 USD 9.14B USD
NASDAQ Composite Total Return I XCMP 19079.55 USD
-5.82
19064.73 USD 19740.96 USD
NASDAQ Capital Market Composite RCMP 92.16 USD
-4.45
89.57 USD 93.85 USD
NASDAQ HealthCare IXHC 869.8 USD
-5.51
868.74 USD 900.72 USD

Stocks Related By Sector

Stocks Related By Industry

Stocks Related By Marketcap